期刊文献+

中年男性高脂血症患者伴发高同型半胱氨酸和高铁蛋白及高尿酸血症情况调查及分析 被引量:1

Survey on the Prevalence of Hyperhomocysteinemia,Hyperferritinaemia and Hyperuricemia in Middle-age Male Patients with Hyperlipidemia
下载PDF
导出
摘要 【目的】调查和分析中年男性高脂血症患者伴发高同型半胱氨酸(Hcy )血症、高铁蛋白(Ferr )血症、高尿酸(U A )血症发生情况。【方法】选取本院40~60岁男性高脂血症患者和同年龄段血脂正常者,经检查无肾病及近期未服用影响 Hcy、Ferr和UA代谢的药物,分别测定其体内 Hcy、Ferr及UA水平。【结果】①高脂血症组Hcy(15.83±5.79μmol/L)、Ferr(330±74ng/mL)、UA(380±90μmol/L)水平均高于血脂正常组 Hcy(8.58±4.26μmol/L)、Ferr(241±87ng/mL)、UA(325±86μmol/L)水平,且两组相比差异均有显著性( P <0.01)。②高脂血症组高 Hcy血症发病率(21.3%)、高Ferr血症发病率(21.6%)、高UA血症发病率(36.5%)均高于血脂正常组高Hcy血症发病率(10.2%)、高Ferr血症发病率(8.1%)、高UA血症发病率(16.8%),且差异均具有显著性( P<0.01)。③不同年龄段之间对比:在高脂血症组和血脂正常组,50~60年龄段 Hcy水平均高于40~49年龄段( P<0.01),而高Hcy血症发病率在两个年龄段之间没有统计学差异( P>0.05);Ferr水平、高Ferr血症发病率、UA水平和高UA血症发病率两个年龄段之间均没有统计学差异( P>0.05)。【结论】中年男性高脂血症者较之血脂正常者有较高的高 Hcy血症、高Ferr血症和高UA血症发病率,且Hcy与Ferr及UA水平也较高。监测这一特殊人群的 Hcy与Ferr及UA水平对指导临床有重要意义。 [Objective]To investigate and analyze the prevalence of hyperhomocysteinemia ,hyperferriti-naemia and hyperuricemia in middle-aged male patients with hyperlipidemia .[Methods]Male patients(aged 40~60 years old) with hyperlipoidemia and subjects with normal blood lipid and the same age in our hospital were chosen .All patients had no nephrosis and recently had not taken drugs affecting the metabolism of homo-cysteine(Hcy) ,ferritin(Ferr) and uric acid(UA) .The levels of Hcy ,Ferr and UA were determined .[Re-sults] The levels of Hcy(15 .83 ± 5 .79μmol/L) ,Ferr(330 ± 74ng/ml) and UA(380 ± 90μmol/L) in hyperlipi-demia group were higher than those in normal group(8 .58 ± 4 .26μmol/L ,241 ± 87ng/ml and 325 ± 86μmol/L , respectively) ,and there was significant difference( P 〈 0 .01) .The morbidity of hyperhomocysteinemia(21 . 3% ) ,hyperferritinaemia(21 .6% ) and hyperuricemia(36 .5% ) in hyperlipidemia group were higher than those in normal group(10 .2% ,8 .1% and 16 .8% ,respectively) ,and there was significant difference( P 〈0 .01) . Different age groups were compared .Hcy level in 50~60 age group was higher than that in 40~49 age group ( P 〈0 .01) ,but there was no significant difference in the morbidity of hyperhomocysteinemia between these two age groups( P〉0 .05) .There was no significant difference in the levels of Ferr and UA and the morbidity of hyperferritinaemia and hyperuricemia between these two age groups ( P 〉 0 .05) .[Conclusion] Compared with normal blood lipid group ,the morbidity of hyperhomocysteinemia ,hyperferritinaemia and hyperuricemia in middle-aged male patients with hyperlipidemia is higher ,and the levels of Hcy ,Ferr and UA are also high-er .It is important to monitor the levels of Hcy ,Ferr and UA in these special people for clinical practice .
出处 《医学临床研究》 CAS 2014年第3期420-422,共3页 Journal of Clinical Research
基金 秦皇岛市科技研究与发展指导计划项目(项目编号:201101A289)
关键词 高脂血症 并发症 高同种半胱氨酸血症 并发症 铁蛋白质类 血液 高尿酸血症 并发症 Hyperlipidemias/CO Hyperhomocysteinemia/CO Ferritins/BL Hyperuricemia/CO
  • 相关文献

参考文献3

二级参考文献36

  • 1庄爱霞,姜建东,刘娟,黄红梅,刘华,曾庆宏.叶酸、维生素B_(12)治疗高同型半胱氨酸血症对颈动脉粥样硬化的影响[J].脑与神经疾病杂志,2011,19(3):209-212. 被引量:16
  • 2樊晓寒,惠汝太.高尿酸血症与心血管病[J].临床心血管病杂志,2007,23(5):323-327. 被引量:62
  • 3Roger VI., Go AS, I.loyd-Jones DM, et al. Heart disease and stroke statistics 2012 update:a report from the American Heart Associa tion[J]. Circulation, 2012,125 ( 1 ) : e2- e220. 被引量:1
  • 4Michael H,Davidson, Kevin C, el al. Results of the national cho lesterol education(NCEP) program evaluation pro.leer utilizing no- vel E-technology (NEPTUNE) Ⅱ survey and implications fortrealment under the recent NCEP wriling group recommendations [J]. The American Journal of Cardiology,2005,96(4):556-563. 被引量:1
  • 5Khandanpour N, Loke YK, Meyer FJ, et al. l[tomocysteine and pe ripheral arterial disease: systematic review and meta-analysis[J]. European Journal of Vascular and Endovascular Surgery,2009,38 (3) :316-322. 被引量:1
  • 6Robert C,Jim H,Derrick B,et al. Homocysteine and vascular dis ease: review of published results of the homocysteine-lowering trl als[J].J Inherit Metab,2011 34(1):83-93. 被引量:1
  • 7Calabro P,Golia E,Yeh ET. CRP and tile risk of atherosclerotic e- vents[J]. Semin Immunopalhol, 2009,31 ( 1 ) : 79-94. 被引量:1
  • 8Blake GJ, Ridker PM. Novel clinical markers of vascular wall in flammation[J]. Circ Res,2001 ,89(9):763-771. 被引量:1
  • 9Mandar S Joshi, Liyue T, Angela C, et al. Increased myocardial prevalence of C reactive protein in human coronary heart disease: direct effects on microvessel density and endothelial cell survival [J]. Cardiovasc Pathol. 2012 Jan 27. 被引量:1
  • 10Biasucci, I.uigi M. CDC/AttA workshop on markers of inflamma- tion and cardiovascular disease: application to clinical and publichealth practice: clinical use of inflammatory markers in patients with cardiovascular diseases: a background paper, 2004,110 (25) : e560-e567. 被引量:1

共引文献13

同被引文献13

  • 1突发性聋的诊断和治疗指南(2005年,济南)[J].中华耳鼻咽喉头颈外科杂志,2006,41(8):569-569. 被引量:850
  • 2刘晓军,蔡东联.高同型半胱氨酸血症致动脉粥样硬化机制研究进展[J].肠外与肠内营养,2007,14(2):120-125. 被引量:17
  • 3CHEN YS, EMMERLING O, ILGNER J, et al. Idiopathic sudden sensorineural hearing loss in children[ J]. Int J Pediatr Otorhinolaryngol,2005,69 (6) :817-821. 被引量:1
  • 4TERANISHI M, KATAYAMA N, UCHIDA Y, et al. Thirty-year trends in sudden deafness from four nationwide epidemiological surveys in Japan [ J ]. Acta Otolaryngol, 2007,127 (12) : 1259 -1265. 被引量:1
  • 5KLEMM E, DEUTSCHER A, MOSGES R. A present investigation of the epidemiology in idiopathic sudden sensorineural hearing loss [ J ]. Laryngorhinootologie, 2009,88 (8) : 524-527. 被引量:1
  • 6MARCUCCI R, ALESSANDRELLO LIOT'I'A A, CELLAI AP, et al. Cardiovascular and thrombophilic risk factors for idiopathic sudden sensorineural hearing loss [ J ]. J Thromb Haemost, 2005,3 ( 5 ) :929-934. 被引量:1
  • 7OROSKOVIC Z, SHEJBAL D, BICANIC G, et al. Influence of lipoproteins and fibrinogen on pathogenesis of sudden sensorineural hearing loss [ J]. J Laryngol Otol,2011,125 (3) : 258-261. 被引量:1
  • 8ROSSENBACH J, MUELLER GA, LANGE K, et al. Lipid-apheresis improves mierocirculation of the upper limbs[ J] . J Clin Apher,2011,26(4) : 167- 173. 被引量:1
  • 9ORITA S,FUKUSHIMA K, ORITA Y,et al. Sudden heating impairment combined with diabetes mellitus or hyperlipidemia [ J ]. Eur Arch Otorhinolaryngol, 2007,264(4) : 359-362. 被引量:1
  • 10WYSOKIN SKI A, KOWMAN M, KLOSZEWSKA I. The prevalence of metabolic syndrome and Framingham cardiovascular risk scores in adult inpatients taking antipsychoties-a retrospective medical records review [ J ]. Psychiatr Danub, 2012, 24(3) : 314-322. 被引量:1

引证文献1

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部